Trastuzumab for patients with HER2 positive breast cancer: delivery, duration and combination therapies. (Q38145791)
Jump to navigation
Jump to search
scientific article published on August 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Trastuzumab for patients with HER2 positive breast cancer: delivery, duration and combination therapies. |
scientific article published on August 2013 |
Statements
Trastuzumab for patients with HER2 positive breast cancer: delivery, duration and combination therapies (English)
Martine Piccart-Gebhart
1 August 2013